格隆汇12月1日丨VITASOY INT'L(00345.HK)发布公告，2025年12月1日耗资1301.62万港元回购197.4万 股，回购价格每股6.54-6.63港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年12月1日 FF305 第 2 頁 共 7 頁 v 1.3.0 FF305 確認 不適用 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | 已發行股份（不包括庫存股份）變動 | 佔有關事件前的現有已發 | 庫存股份變動 | ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 維他奶國際集團有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 不適用 FF301 第 1 頁 共 11 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 1,049,545,089 | | 0 | | 1,049,545,089 | | 增加 / 減少 (-) | | | -6,016,000 | | 0 | | | | 本月底結存 | | | 1,043,529,089 | | 0 | | ...

VITASOY INT'L回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.11.28 | 171.00 | 6.610 | 6.430 | 1119.61 | | 2025.11.27 | 395.20 | 6.700 | 6.480 | 2592.67 | | 2025.11.26 | 396.20 | 6.790 | 6.510 | 2662.46 | | 2025.10.22 | 23.00 | 8.040 | 8.010 | 184.67 | | 2025.10.21 | 12.00 | 8.040 | 8.040 | 96.48 | | 2025.10.17 | 102.00 | 8.040 | 8.020 | 819.55 | | 2025.10.16 | 2.00 | 8.180 | 8.180 | 16.36 | | 2025.10.15 | 37.60 | 8.180 | 8.100 | 307.09 | | 2025.10.14 | 139.8 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年11月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括 ...

Core Points - VITASOY INT'L has conducted share buybacks, repurchasing 3.952 million shares at prices ranging from HKD 6.480 to HKD 6.700, totaling HKD 25.93 million on November 27 [2] - The stock closed at HKD 6.500 on the same day, reflecting a decline of 3.13%, with a total trading volume of HKD 54.96 million [2] - Since November 26, the company has repurchased a total of 7.914 million shares, amounting to HKD 52.55 million, during which the stock has decreased by 2.69% [2] Buyback Summary - Year-to-date, VITASOY INT'L has executed 48 buybacks, totaling 38.36 million shares and an aggregate buyback amount of HKD 331 million [3] - Detailed buyback transactions include: - November 27: 395.20 thousand shares at a maximum price of HKD 6.700 and a minimum price of HKD 6.480, totaling HKD 25.93 million [3] - November 26: 396.20 thousand shares at a maximum price of HKD 6.790 and a minimum price of HKD 6.510, totaling HKD 26.62 million [3] - Other notable buybacks occurred on October 22, October 21, and earlier dates, with varying amounts and prices [4]

Core Viewpoint - Vitasoy International reported a 6% decline in revenue for the first half of the 2025/2026 fiscal year, primarily due to a weak market and intensified competition in the plant-based milk sector, posing challenges for the company's growth [2] Revenue Performance - The company's revenue for the first half of the fiscal year was HKD 3.227 billion, down from the previous year [2] - Revenue from mainland China decreased by 9.19% to HKD 1.778 billion, while net profit fell by 12.45% to HKD 192 million [3] - Mainland China accounts for approximately 55% of Vitasoy's total revenue and 63.07% of its net profit [3] Strategic Initiatives - To counteract declining sales, Vitasoy implemented cost optimization measures, maintaining an operating profit margin of 11% in mainland China [3] - The company introduced innovative products like the "Vitasoy Lemon Tea" to enhance its market share in the ready-to-drink tea category [3] - A price reduction of 10%-15% for Vitasoy Lemon Tea was attempted to respond to industry price wars, resulting in increased market share [3] Market Challenges - Vitasoy's business in Hong Kong also faced growth pressures, with a 4% revenue decline attributed to weak performance in its Vitasoy Tian Di business and adverse weather conditions affecting sales [4] - The company continues to hold a leading position in the non-alcoholic beverage market in Hong Kong, supported by successful product launches [4] Long-term Outlook - Despite short-term challenges, the company remains confident in its long-term growth potential, aiming to increase the proportion of low-sugar or no-added-sugar products to 80% by the 2030/2031 fiscal year [5] - The company is focusing on expanding its presence in southern China and Southeast Asia to capture growth opportunities [6]

Core Viewpoint - Vitasoy International reported a 6% decline in revenue for the first half of the 2025/2026 fiscal year, totaling HKD 3.227 billion, primarily due to a weak market and intensified competition in the plant-based milk sector [1] Revenue Performance - Revenue from mainland China decreased by 9.19% to HKD 1.778 billion, while net profit fell by 12.45% to HKD 192 million, with mainland China accounting for approximately 55% of total revenue and 63.07% of net profit [3] - The overall revenue decline was attributed to a contraction in traditional retail channels, despite maintaining an operating profit margin of 11% through cost optimization measures [4] Product Strategy - Vitasoy introduced innovative products like the "Vitasoy Lemon Tea" to enhance market share in the ready-to-drink tea category amid slowing growth in plant-based and tea products [4] - A price reduction of approximately 10%-15% for Vitasoy Lemon Tea was implemented to respond to industry price wars, resulting in increased market share [4] Market Challenges - The Hong Kong business also faced growth pressures, with a 4% revenue decline attributed to weak performance in Vitasoy's subsidiary, Macau, and export markets [5] - Adverse weather conditions during the typhoon season negatively impacted business operations, particularly in the Vitasoy subsidiary [5] Competitive Landscape - Vitasoy faces significant competition from companies like Mengniu, Yili, and DaLi Foods, which have launched their own soy milk products, as well as the rise of sugar-free tea and ready-to-drink brands that compete with Vitasoy's offerings [6] - The company plans to increase the proportion of low-sugar or no-added-sugar products to 80% by the 2030/2031 fiscal year to align with health-conscious consumer trends [6] Future Outlook - Analysts suggest that Vitasoy's focus on cost reduction and efficiency improvements, along with potential market opportunities in southern China and Southeast Asia, could support future growth [7]

格隆汇11月27日丨VITASOY INT'L(00345.HK)发布公告，2025年11月27日耗资2592.67万港元回购395.2 万股，回购价格每股6.48-6.7港元。 本文源自：格隆汇 ...

智通财经APP讯，VITASOY INT'L(00345)发布公告，于2025年11月27日斥资2592.67万港元回购395.2万 股。 （原标题：VITASOY INT'L(00345)11月27日斥资2592.67万港元回购395.2万股） ...